Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
about
Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitisHepatotoxicity Associated with the Use of Anti-TNF-α AgentsEffectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs.Correction: Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis.The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.Monitoring patients with ankylosing spondylitis on anti-TNF monotherapy: too much too often?
P2860
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
@ast
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
@en
type
label
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
@ast
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
@en
prefLabel
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
@ast
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
@en
P2093
P2860
P1433
P1476
Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis
@en
P2093
Dongbao Zhao
Qiang Tong
Tristan de Mooij
Wenchun Qu
P2860
P304
P356
10.1371/JOURNAL.PONE.0119897
P407
P577
2015-03-12T00:00:00Z